Fei Cao
Chief Executive Officer bij HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.
Vermogen: 288 223 $ op 31-03-2024
Profiel
Fei Cao has held positions at Hubei Jumpcan Pharmaceutical Co., Ltd.
and Jumpcan Pharmaceutical Co. Ltd.
His current job titles include Vice Chairman & General Manager at Hubei Jumpcan Pharmaceutical Co., Ltd.
and Director at Jumpcan Pharmaceutical Co. Ltd.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
13-09-2022 | 1 961 500 ( 0.15% ) | 288 223 $ | 31-03-2024 |
Actieve functies van Fei Cao
Bedrijven | Functie | Begin |
---|---|---|
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 20-12-2019 |
Jumpcan Pharmaceutical Co. Ltd.
Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the private company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million. | Director/Board Member | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Jumpcan Pharmaceutical Co. Ltd.
Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the private company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million. | Health Technology |